Acupuncture Therapy for COVID-Related Olfactory Loss

• Status: Recruiting
• Trial end date: 2023-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• 18 years or older.

• Patients with post-viral olfactory dysfunction > 4 weeks.

• History of positive COVID-19 PCR.

Exclusion Criteria:

• Less than 18 years of age.

• Active sinus infection.

• New diagnosis of untreated CRS.

• Prior diagnosis of dementia or Parkinson's disease.

• Prior head trauma or neurosurgical procedure resulting in olfactory loss.

• Patients who do not speak or read English.

• Patients unable to understand and sign the study consent.